IL24 and neoplasm: Enhanced tumor suppression was shown by nonreplicating bicistronic Ad vector expressing both ING4 and IL-24 genes employed for treatment of human non-small cell lung cancer, breast cancer, and hepatocarcinoma subcutaneous tumor xenografts [37–40].